vs
GIBRALTAR INDUSTRIES, INC.（ROCK）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是再鼎医药的1.8倍（$225.0M vs $127.1M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 17.1%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -12.3%）
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
ROCK vs ZLAB — 直观对比
营收规模更大
ROCK
是对方的1.8倍
$127.1M
营收增速更快
ROCK
高出7.8%
17.1%
自由现金流更多
ROCK
多$52.9M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.0M | $127.1M |
| 净利润 | — | — |
| 毛利率 | 25.3% | 51.0% |
| 营业利润率 | 7.9% | -54.6% |
| 净利率 | — | — |
| 营收同比 | 24.9% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ROCKZLAB
| Q4 25 | $225.0M | $127.1M | ||
| Q3 25 | $310.9M | $115.4M | ||
| Q2 25 | $309.5M | $109.1M | ||
| Q1 25 | $290.0M | $105.7M | ||
| Q4 24 | $180.1M | $108.5M | ||
| Q3 24 | $277.1M | $101.8M | ||
| Q2 24 | $273.6M | $100.1M | ||
| Q1 24 | $292.5M | $87.1M |
净利润ROCKZLAB
| Q4 25 | — | — | ||
| Q3 25 | $-89.1M | $-36.0M | ||
| Q2 25 | $26.0M | $-40.7M | ||
| Q1 25 | $21.1M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $34.0M | $-41.7M | ||
| Q2 24 | $32.2M | $-80.3M | ||
| Q1 24 | $24.9M | $-53.5M |
毛利率ROCKZLAB
| Q4 25 | 25.3% | 51.0% | ||
| Q3 25 | 26.6% | 59.5% | ||
| Q2 25 | 28.4% | 60.6% | ||
| Q1 25 | 26.8% | 63.6% | ||
| Q4 24 | 29.0% | 61.5% | ||
| Q3 24 | 29.4% | 64.1% | ||
| Q2 24 | 30.5% | 64.9% | ||
| Q1 24 | 28.9% | 61.4% |
营业利润率ROCKZLAB
| Q4 25 | 7.9% | -54.6% | ||
| Q3 25 | 12.8% | -42.3% | ||
| Q2 25 | 12.8% | -50.3% | ||
| Q1 25 | 8.8% | -53.3% | ||
| Q4 24 | 13.3% | -62.6% | ||
| Q3 24 | 15.6% | -66.6% | ||
| Q2 24 | 14.9% | -76.0% | ||
| Q1 24 | 10.8% | -80.7% |
净利率ROCKZLAB
| Q4 25 | — | — | ||
| Q3 25 | -28.6% | -31.2% | ||
| Q2 25 | 8.4% | -37.3% | ||
| Q1 25 | 7.3% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 12.3% | -40.9% | ||
| Q2 24 | 11.8% | -80.2% | ||
| Q1 24 | 8.5% | -61.4% |
每股收益（稀释后）ROCKZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $-2.98 | $-0.03 | ||
| Q2 25 | $0.87 | $-0.04 | ||
| Q1 25 | — | $-0.04 | ||
| Q4 24 | — | $-0.09 | ||
| Q3 24 | $1.11 | $-0.04 | ||
| Q2 24 | $1.05 | $-0.08 | ||
| Q1 24 | — | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.7M | $689.6M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $950.4M | $715.5M |
| 总资产 | $1.4B | $1.2B |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ROCKZLAB
| Q4 25 | $115.7M | $689.6M | ||
| Q3 25 | $89.4M | $717.2M | ||
| Q2 25 | $43.3M | $732.2M | ||
| Q1 25 | $25.1M | $757.3M | ||
| Q4 24 | $269.5M | $779.7M | ||
| Q3 24 | $228.9M | $616.1M | ||
| Q2 24 | $179.1M | $630.0M | ||
| Q1 24 | $146.7M | $650.8M |
总债务ROCKZLAB
| Q4 25 | $0 | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $0 | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — |
股东权益ROCKZLAB
| Q4 25 | $950.4M | $715.5M | ||
| Q3 25 | $951.8M | $759.9M | ||
| Q2 25 | $1.0B | $791.7M | ||
| Q1 25 | $1.0B | $810.8M | ||
| Q4 24 | $1.0B | $840.9M | ||
| Q3 24 | $1.0B | $667.7M | ||
| Q2 24 | $975.7M | $704.2M | ||
| Q1 24 | $940.2M | $762.2M |
总资产ROCKZLAB
| Q4 25 | $1.4B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $1.4B | $1.2B | ||
| Q3 24 | $1.4B | $985.3M | ||
| Q2 24 | $1.4B | $987.4M | ||
| Q1 24 | $1.3B | $988.4M |
负债/权益比ROCKZLAB
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.5M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $26.2M | $-26.7M |
| 自由现金流率自由现金流/营收 | 11.7% | -21.0% |
| 资本支出强度资本支出/营收 | 4.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $120.6M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流ROCKZLAB
| Q4 25 | $35.5M | $-26.0M | ||
| Q3 25 | $73.0M | $-32.0M | ||
| Q2 25 | $44.9M | $-31.0M | ||
| Q1 25 | $13.7M | $-61.7M | ||
| Q4 24 | $19.9M | $-55.8M | ||
| Q3 24 | $64.7M | $-26.8M | ||
| Q2 24 | $36.5M | $-42.2M | ||
| Q1 24 | $53.2M | $-90.1M |
自由现金流ROCKZLAB
| Q4 25 | $26.2M | $-26.7M | ||
| Q3 25 | $64.8M | $-35.0M | ||
| Q2 25 | $27.3M | $-33.9M | ||
| Q1 25 | $2.3M | $-63.2M | ||
| Q4 24 | $14.1M | $-58.4M | ||
| Q3 24 | $60.5M | $-28.2M | ||
| Q2 24 | $33.5M | $-42.9M | ||
| Q1 24 | $48.8M | $-91.1M |
自由现金流率ROCKZLAB
| Q4 25 | 11.7% | -21.0% | ||
| Q3 25 | 20.8% | -30.4% | ||
| Q2 25 | 8.8% | -31.1% | ||
| Q1 25 | 0.8% | -59.9% | ||
| Q4 24 | 7.8% | -53.8% | ||
| Q3 24 | 21.8% | -27.7% | ||
| Q2 24 | 12.2% | -42.9% | ||
| Q1 24 | 16.7% | -104.5% |
资本支出强度ROCKZLAB
| Q4 25 | 4.1% | 0.5% | ||
| Q3 25 | 2.6% | 2.6% | ||
| Q2 25 | 5.7% | 2.6% | ||
| Q1 25 | 3.9% | 1.5% | ||
| Q4 24 | 3.3% | 2.4% | ||
| Q3 24 | 1.5% | 1.3% | ||
| Q2 24 | 1.1% | 0.7% | ||
| Q1 24 | 1.5% | 1.1% |
现金转化率ROCKZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.73× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 2.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
